Literature DB >> 8130071

Growth factors, mitogens, oncogenes and the regulation of glucose transport.

N W Merrall1, R Plevin, G W Gould.   

Abstract

The erythrocyte (or HepG2/brain) type glucose transporter (GLUT 1) was the first of the family of facilitative glucose transporter proteins to be cloned [M. Mueckler et al., Science 229, 941-945, 1985]. GLUT 1 is expressed in most tissue types, all cell lines, transformed cells and tumour cells. It is thought to be responsible for "housekeeping" levels of glucose transport, i.e. the uptake of glucose required for oxidative phosphorylation. The rate of glucose transport via GLUT 1 can be regulated under conditions in which the metabolic rate must be adjusted such as cell division (mitosis and meiosis), differentiation, transformation and nutrient starvation. Here we review the recent literature on the control of glucose transport of mitogens, growth factors and oncogenes, and discuss some of the implications for the integration of cellular signalling pathways and cell growth.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8130071     DOI: 10.1016/0898-6568(93)90028-k

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  20 in total

1.  Requirements for clinical PET: comparisons within Europe.

Authors:  Michael Bedford; Michael N Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

2.  [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.

Authors:  Marcelo Mamede; Tatsuya Higashi; Masanori Kitaichi; Koichi Ishizu; Takayoshi Ishimori; Yuji Nakamoto; Kazuhiro Yanagihara; Mio Li; Fumihiro Tanaka; Hiromi Wada; Toshiaki Manabe; Tsuneo Saga
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

3.  Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.

Authors:  J D Burke; L C Platanias; E N Fish
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

4.  Thrombin-induced translocation of GLUT3 glucose transporters in human platelets.

Authors:  L R Sorbara; T M Davies-Hill; E M Koehler-Stec; S J Vannucci; M K Horne; I A Simpson
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

5.  Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.

Authors:  Roger G O'Neil; Ling Wu; Nizar Mullani
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

6.  Glut-1 Expression Correlates with Basal-like Breast Cancer.

Authors:  Yaser R Hussein; Sudeshna Bandyopadhyay; Assaad Semaan; Quratulain Ahmed; Bassam Albashiti; Tarek Jazaerly; Zeina Nahleh; Rouba Ali-Fehmi
Journal:  Transl Oncol       Date:  2011-12-01       Impact factor: 4.243

Review 7.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

8.  Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma.

Authors:  Xiao-Hong Wu; Su-Ping Chen; Jian-Ying Mao; Xue-Xian Ji; Hong-Tian Yao; Shui-Hong Zhou
Journal:  Oncol Lett       Date:  2012-09-26       Impact factor: 2.967

9.  A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment.

Authors:  Timothy H Witney; Mikko I Kettunen; Samuel E Day; De-en Hu; Andre A Neves; Ferdia A Gallagher; Sandra M Fulton; Kevin M Brindle
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

10.  Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.

Authors:  Erito Mochiki; Hiroyuki Kuwano; Hiroyuki Katoh; Takayuki Asao; Noboru Oriuchi; Keigo Endo
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.